Session Details
[29-57-pm1]Social Pharmacy 11, Pharmacoepidemiology/Prevention of drug abuse
Sun. Mar 29, 2026 1:10 PM - 3:10 PM JST
Sun. Mar 29, 2026 4:10 AM - 6:10 AM UTC
Sun. Mar 29, 2026 4:10 AM - 6:10 AM UTC
Room 57 (C205, Bldg. 2, Area 2 [2F])
Discusser: Tetsushi Kawazoe, Shinobu Imai
[29-57-pm1-01]Drug Utilization during Pregnancy in Japan: A Study from 2012 to 2023
○Tomofumi Ishikawa1, Nariyasu Mano1,2, Taku Obara2,3,4 (1. Laboratory of Biomolecule and Pathophysiological Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 2. Department of Pharmaceutical Sciences, Tohoku University Hospital, 3. Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, 4. Division of Molecular Epidemiology, Graduate School of Medicine, Tohoku University)
[29-57-pm1-02]Risk of major congenital malformations associated with the first-trimester exposure to antipsychotics: A large claims database study
○Ryo Obara1, Takamasa Sakai2, Tomofumi Ishikawa3, Kei Morishita1,4, Motohiko Adomi5, Azusa Hara6, Saya Kikuchi1,7, Natsuko Kobayashi1,7, Noriyuki Iwama8,9, Genki Shinoda1,8, Aoi Noda1,4,8, Masatsugu Orui1,8,10, Mami Ishikuro1,8, Hiroaki Tomita1,7,10, Nariyasu Mano3,4, Shinichi Kuriyama1,8,10, Taku Obara1,4,8 (1. Grad. Sch. Med., Tohoku Univ., 2. Fac. Pharm., Meijo Univ., 3. Grad. Sch. Pharm. Sci., Tohoku Univ., 4. Dept. Pharm., Tohoku Univ. Hosp., 5. Harvard Chan Sch. Public Health, Harvard Univ., 6. Showa Pharm. Univ., 7. Dept. Psychiatry, Tohoku Univ. Hosp., 8. Tohoku Med. Megabank Org., Tohoku Univ., 9. Ctr. Matern. & Perinat. Med., Tohoku Univ. Hosp., 10. Int. Res. Inst. Disaster Sci., Tohoku Univ.)
[29-57-pm1-03S]Effectiveness of Immunosuppressants for Low-Dose Glucocorticoid Maintenance in Patients with Takayasu Arteritis and Giant Cell Arteritis
○Koki Nakahara1, Yukumitsu Kudo1, Misaki Takada1, Kotaro Kawano1, Sari Horiuchi1, Takahiko Sugihara2, Yoshikazu Nakaoka3, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji Pharmaceutical University, 2. Toho University, 3. National Cerebral and Cardiovascular Center)
[29-57-pm1-04S]Validation study of algorithms to identify cancer-related neuropathic pain and evaluation of risk factors for pregabalin discontinuation using hospital-based DPC data
○Saaya Seki1, Amon Omi1, Shinsuke Tajima1,2, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji Pharm. Univ., 2. Dept. of Pharm., Kyorin Univ. Hosp.)
[29-57-pm1-05]Introduction of sports pharmacist service at Juntendo University Hospital to promote health and sports science
○Yuri Kimura1,2, Kosuke Fukao2,3, Akane Ota1, Ayako Nakahira1, Yuka Murofushi2, Yutaka Fukaya1, Chiba Takeshi1,4 (1. Dep. Pharm., Juntendo Univ., 2. Fac. Health Sci., Juntendo. Univ., 3. Fac. Med., Juntendo Univ., 4. Fac. Pharm., Juntendo Univ.)
[29-57-pm1-06S]Effectiveness of tocilizumab for steroid tapering in patients with Takayasu arteritis and giant cell arteritis
○Misaki Takada1, Yukumitsu Kudo1, Kouki Nakahara1, Sari Horiuchi1, Kotaro Kawano1, Takahiko Sugihara2, Yoshikazu Nakaoka3, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji Pharmaceutical University, 2. Toho University, 3. National Cerebral and Cardiovascular Center)
[29-57-pm1-07S]FAERS-based comparison of cardiometabolic safety between long-acting cabotegravir/rilpivirine and first-line oral INSTI-based regimens
○Chihiro Nishikawa1, Shigeru Hasebe1, Yuki Miura1, Maho Kikuta1 (1. Fac. Pharm. Sci., Setsunan Univ.)
[29-57-pm1-08]The importance of visualizing non-reimbursable activities in community pharmacy practice -Reports of insurance-designated pharmacies situated on hospital grounds
○Ayumi Fujita1, Kazuaki Yabe1, Masahiro Yamamoto1, Yuuho Nakayama1, Naoto Enomoto1, Shinya Sugiura1,2 (1. SUGI Pharmacy Co., Ltd., 2. Grad. Sch. Pharm. Sci., Teikyo Heisei Univ.)
[29-57-pm1-09S]Temporal trends in early-onset stroke incidence in Japan, 2014–2023: a claims-database study
○Ankhtuya Batsukh1, Byambajav Tserenlkham 1, Noriko Tagawa1, Atsushi Satoh1, Yukako Hatanaka1, Sachiko Tanaka1 (1. Kobe Pharmaceutical University)